Summit Global Investments’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Buy
+4,789
New +$201K 0.02% 463
2026
Q1
Sell
-5,886
Closed -$248K 537
2025
Q4
$248K Sell
5,886
-3,885
-40% -$157K 0.01% 436
2025
Q3
$335K Buy
+9,771
New +$280K 0.02% 380
2021
Q2
Sell
-4,100
Closed -$220K 631
2021
Q1
$220K Buy
+4,100
New +$236K 0.01% 507

Other funds holding VCYT

Summit Global Investments's VCYT Position: Q2 2026 in Review

Summit Global Investments opened a new position in Veracyte (VCYT) in Q2 2026: 4,789 shares worth $281K. The stake represents 0.02% of the portfolio and ranks #463 among its holdings. This is a return to the name: Summit Global Investments previously reported a position in VCYT as recently as Q4 2025.

Summit Global Investments first reported a position in VCYT in Q1 2021 and has held it in 4 quarters since. The position peaked at $335K in Q3 2025. 92 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Summit Global Investments held 4,789 shares of Veracyte worth $281K as of Q2 2026.
  • Veracyte was a new Summit Global Investments position in Q2 2026.
  • Veracyte made up 0.02% of Summit Global Investments's portfolio in Q2 2026, its #463 holding.
  • Summit Global Investments first reported a position in Veracyte in Q1 2021 and has held it in 4 quarters since.
  • Summit Global Investments's Veracyte position peaked at $335K in Q3 2025.
  • 92 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.